I want to assure the committee that the provinces were not consulted and the stakeholders were not consulted. R and D was obviously consulted, but the generics weren't consulted. I don't want to get into a battle of one over the other. I'm pleased to see that we're going to send a letter saying to the minister, “Don't do this again”. The damage will already have been done.
I suggest we get on with the vote, Chair. I know you have to get on with this. I think the lines are very clear. Ms. Nash and I have a problem with this. We'll see how this results.
I'm wearing my consumer critic hat. I'm very concerned about this. I'm also concerned that when there were changes in 2006--you'll recall, Mr. Chair--we actually gave data protection back to the industry. We couldn't acknowledge what the Americans, Europeans, and everybody said: that this was far too generous. They received at that time a far more generous opportunity to get a trade-off, which seems to have been lost in time.
I'd like to see consultation, but frankly it's very one-sided. I think that's the position of the department--it hasn't changed. I'm pleased to see that we would like to move on with this, but if we send a letter, I think the minister will look at it and say “Thanks very much. We'll move on.”
Thank you, Chair.